Rosuvastatin augments dipyridamole induced vasodilation by increased adenosine receptor stimulation

Registry ID
EUCTR2007-004762-40
Source registry
EUCTR
Status
Ongoing
Phase
PHASE4
Sponsor
Dept. Pharmacology and Toxicology
Start date
2007-09-21
Last update
2026-08-16

Conditions

Summary

To determine whether a one-week treatment with rosuvastatin augments dipyridamole-induced forearm vasodilation by increased adenosine receptor stimulation.

Locations

Related clinical trials

View on source registry